Kennedy Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.7M	Sell	1,199,598 -10,094	-0.8%	-$240K	0.63%	20
2025 Q4	$28.2M	Buy	1,209,692 +149,485	+14%	+$3.33M	0.6%	21
2025 Q3	$20.9M	Buy	1,060,207 +50,746	+5%	+$1.04M	0.46%	44
2025 Q2	$21.9M	Sell	1,009,461 -51,862	-5%	-$1.22M	0.52%	30
2025 Q1	$25.7M	Buy	1,061,323 +43,657	+4%	+$983K	0.61%	18
2024 Q4	$21.2M	Sell	1,017,666 -23,750	-2%	-$510K	0.47%	30
2024 Q3	$20.7M	Sell	1,041,416 -234,888	-18%	-$4.35M	0.46%	32
2024 Q2	$19.8M	Buy	1,276,304 +214,600	+20%	+$3.34M	0.42%	42
2024 Q1	$16.9M	Buy	1,061,704 +533,802	+101%	+$8.04M	0.35%	70
2023 Q4	$8.87M	Sell	527,902 -108,464	-17%	-$1.48M	0.19%	197
2023 Q3	$7.44M	Buy	636,366 +333,562	+110%	+$4.46M	0.18%	206
2023 Q2	$4.07M	Buy	+302,804	New	+$4.36M	0.09%	337
2019 Q2	–	Sell	-999,787	Closed	-$5.1M	–	696
2019 Q1	$5.1M	Buy	+999,787	New	+$2.94M	0.12%	323
2018 Q4	–	Sell	-1,042,645	Closed	-$3.94M	–	696
2018 Q3	$3.94M	Sell	1,042,645 -11,226	-1%	-$35.2K	0.07%	470
2018 Q2	$3.29M	Buy	1,053,871 +237,300	+29%	+$720K	0.06%	521
2018 Q1	$1.95M	Sell	816,571 -74,603	-8%	-$248K	0.04%	605
2017 Q4	$3.48M	Sell	891,174 -9,444	-1%	-$31.2K	0.06%	529
2017 Q3	$2.27M	Sell	900,618 -17,820	-2%	-$48.9K	0.04%	594
2017 Q2	$2.54M	Buy	918,438 +687,938	+298%	+$1.44M	0.05%	553
2017 Q1	$449K	Sell	230,500 -2,671	-1%	-$3.4K	0.01%	697
2016 Q4	$245K	Sell	233,171 -10,065	-4%	-$11.5K	﹤0.01%	703
2016 Q3	$265K	Sell	243,236 -4,475	-2%	-$4.03K	0.01%	696
2016 Q2	$176K	Buy	247,711 +3,259	+1%	+$2.63K	﹤0.01%	696
2016 Q1	$286K	Sell	244,452 -3,765	-2%	-$5.84K	0.01%	711
2015 Q4	$608K	Sell	248,217 -854	-0.3%	-$2.45K	0.01%	690
2015 Q3	$747K	Buy	+249,071	New	+$1.08M	0.02%	671